ANIK logo

ANIK
Anika Therapeutics Inc.

643
Mkt Cap
$204.11M
Volume
123,840.00
52W High
$16.24
52W Low
$7.87
PE Ratio
-19.38
ANIK Fundamentals
Price
$15.34
Prev Close
$14.80
Open
$14.84
50D MA
$14.72
Beta
0.90
Avg. Volume
131,525.03
EPS (Annual)
-$0.7588
P/B
1.53
Rev/Employee
$480,080.85
$106.56
Loading...
Loading...
News
all
press releases
Anika Therapeutics (NASDAQ:ANIK) Director John Henneman III Buys 5,000 Shares
Anika Therapeutics Inc. (NASDAQ:ANIK - Get Free Report) Director John Henneman III acquired 5,000 shares of the stock in a transaction on Friday, May 1st. The shares were acquired at an average price of $14.66 per share, with a total value of $73,300.00. Following the transaction, the director...
MarketBeat·11d ago
News Placeholder
More News
News Placeholder
Anika Therapeutics (NASDAQ:ANIK) CEO Stephen Griffin Purchases 12,200 Shares
Anika Therapeutics Inc. (NASDAQ:ANIK - Get Free Report) CEO Stephen Griffin purchased 12,200 shares of the firm's stock in a transaction that occurred on Thursday, April 30th. The shares were bought...
MarketBeat·14d ago
News Placeholder
Anika Therapeutics (NASDAQ:ANIK) CEO Purchases $149,938.00 in Stock
Anika Therapeutics Inc. (NASDAQ:ANIK - Get Free Report) CEO Stephen Griffin bought 12,200 shares of the firm's stock in a transaction on Thursday, April 30th. The stock was purchased at an average...
MarketBeat·14d ago
News Placeholder
Anika Therapeutics (NASDAQ:ANIK) Releases Earnings Results, Misses Expectations By $0.17 EPS
Anika Therapeutics (NASDAQ:ANIK - Get Free Report) posted its quarterly earnings data on Wednesday. The biotechnology company reported ($0.24) EPS for the quarter, missing analysts' consensus...
MarketBeat·16d ago
News Placeholder
Anika Therapeutics Q1 Earnings Call Highlights
Anika Therapeutics (NASDAQ:ANIK) reported first-quarter 2026 results highlighting continued momentum in its commercial channel, progress in its hyaluronic acid (HA)-based product pipeline, and early...
MarketBeat·16d ago
News Placeholder
Anika Therapeutics (NASDAQ:ANIK) Share Price Crosses Above Two Hundred Day Moving Average - Time to Sell?
Anika Therapeutics (NASDAQ:ANIK) Stock Price Passes Above Two Hundred Day Moving Average - Time to Sell...
MarketBeat·27d ago
News Placeholder
Anika Therapeutics (NASDAQ:ANIK) Stock Crosses Above 200 Day Moving Average - Should You Sell?
Anika Therapeutics (NASDAQ:ANIK) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell...
MarketBeat·1mo ago
News Placeholder
Anika Therapeutics (NASDAQ:ANIK) Share Price Passes Above 200 Day Moving Average - What's Next?
Anika Therapeutics (NASDAQ:ANIK) Stock Passes Above 200 Day Moving Average - What's Next...
MarketBeat·1mo ago
News Placeholder
Anika Therapeutics (NASDAQ:ANIK) Share Price Crosses Above 200-Day Moving Average - Time to Sell?
Anika Therapeutics (NASDAQ:ANIK) Share Price Crosses Above 200-Day Moving Average - Here's Why...
MarketBeat·2mo ago
News Placeholder
Anika Therapeutics (NASDAQ:ANIK) Shares Pass Above 200-Day Moving Average - What's Next?
Anika Therapeutics (NASDAQ:ANIK) Share Price Passes Above 200-Day Moving Average - Here's What Happened...
MarketBeat·2mo ago
<
1
2
...
>

Latest ANIK News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.